RE:RE:RE:RE:RE:RE:RE:The prescriber base has doubled for Trogarzo In the next couple of years the company will be negotiating much larger financings and potentially billion dollar licensing agreements. Given Thera's track record do you believe they have the proper management in place to execute those agreements and get the best possible terms for shareholders?
FredTheVoice wrote: JEFF this is just short term frustrations view that you are spreading on this board.....
Lets just wait, and I am pretty sure a lot here are ready to say that in two years, with oncology and NASH on the roll, with some results out, TH will see no problem with that 50M your are talking about (convertable...).
You really think TH shares wont be worth more than 15$C a share next year ?
If so, its time to sell and invest in an another company.....
All my respect on a bad day,
BLTA.
FTV.